A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Conditions: Localized Osteosarcoma; Metastatic Osteosarcoma; Resectable Osteosarcoma; Unresectable Osteosarcoma Interventions: Drug: Cabozantinib S-malate; Drug: Methotrexate; Drug: Doxorubicin Hydrochloride; Drug: Cisplatin; Procedure: X-Ray Imaging; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Bone Scan Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials
Roflumilast Versus Methotrexate in Psoriasis
Condition: Psoriasis Interventions: Drug: Roflumilast; Drug: Methotrexate Sponsor: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Conditions: Localized Osteosarcoma; Metastatic Osteosarcoma; Resectable Osteosarcoma; Unresectable Osteosarcoma Interventions: Drug: Cabozantinib S-malate; Drug: Methotrexate; Drug: Doxorubicin Hydrochloride; Drug: Cisplatin; Procedure: X-Ray Imaging; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Bone Scan Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials
Roflumilast Versus Methotrexate in Psoriasis
Condition: Psoriasis Interventions: Drug: Roflumilast; Drug: Methotrexate Sponsor: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Conditions: Localized Osteosarcoma; Metastatic Osteosarcoma; Resectable Osteosarcoma; Unresectable Osteosarcoma Interventions: Drug: Cabozantinib S-malate; Drug: Methotrexate; Drug: Doxorubicin Hydrochloride; Drug: Cisplatin; Procedure: X-Ray Imaging; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Bone Scan Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials